Top

Published in:

01-12-2012 | Review Article

Probiotics: a potential role in the prevention of gestational diabetes?

Authors: Helen L. Barrett, Leonie K. Callaway, Marloes Dekker Nitert

Published in: Acta Diabetologica | Special Issue 1/2012

Abstract

The gut microbiome has a complex relationship with host metabolism and immune function. Host health and diet influence the composition of the gut microbiome, and conversely, different microbiome compositions influence host metabolism. Gestational diabetes mellitus is increasingly common and has serious implications for maternal and foetal health both during pregnancy and later in life. To date, clinical trials of exercise and dietary interventions to prevent the onset of gestational diabetes have had heterogeneous results and have proven disappointingly difficult. Alternative prevention strategies of gestational diabetes mellitus need to be considered and trialled in a placebo-controlled manner in combination with dietary and behavioural measures. One such potential preventative therapy is probiotic supplementation, that is, ingestion of specific bacterial strains with beneficial effects on the host. Probiotic supplements have been shown to improve metabolism by increasing host insulin sensitivity, cholesterol metabolism and also have a beneficial effect on the immune system. This discussion paper examines the evidence for the influence of the gut microbiome on host metabolism and the potential metabolic impact of probiotic supplementation, with particular regard for the evidence surrounding a possible use of probiotic supplements for the prevention of gestational diabetes. Probiotics offer the tantalising possibility of a feasible intervention for the prevention of gestational diabetes and improvement of metabolic syndromes, but there is a pressing need for further studies of the mechanisms underlying the apparent metabolic benefits and for the use of randomised controlled trials to allow examination of the effectiveness of probiotic supplementation in this setting.

Committee ACOG (2005) ACOG Committee Opinion number 315, September 2005. Obesity in pregnancy. Obstet Gynecol 106(3):671–675CrossRef

Kuhl C (1998) Etiology and pathogenesis of gestational diabetes. Diabetes Care 21(Suppl 2):B19–B26PubMed

Richardson AC, Carpenter MW (2007) Inflammatory mediators in gestational diabetes mellitus. Obstet Gynecol Clin North Am 34(2):213–224PubMedCrossRef

Lopez-Tinoco C, Roca M, Fernandez-Deudero A, Garcia-Valero A, Bugatto F, Aguilar-Diosdado M, Bartha JL (2012) Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine 58(1):14–19PubMedCrossRef

Centers for Disease Control and Prevention (2011) National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention

The HAPO Study Cooperative Research Group (2008) Hyperglycemia and adverse pregnancy outcomes. NEJM 358:1991–2002CrossRef

Savona-Ventura C, Vassallo J, Marre M, Karamanos BG, Group MGS (2012) Hyperglycaemia in pregnancy in Mediterranean women. Acta Diabetol [Epub ahead of print]

Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, for the Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group* (2005) Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes. NEJM 352 (24):2477–2486

Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB, Eunice Kennedy Shriver National Institute of Child H, Human Development Maternal-Fetal Medicine Units N (2009) A multicenter, randomized trial of treatment for mild gestational diabetes [see comment]. NEJM 361(14):1339–1348PubMedCrossRef

10.

Dodd JM, Grivell RM, Crowther CA, Robinson JS (2010) Antenatal interventions for overweight or obese pregnant women: a systematic review of randomised trials. BJOG 117(11):1316–1326PubMedCrossRef

11.

Streuling I, Beyerlein A, von Kries R (2010) Can gestational weight gain be modified by increasing physical activity and diet counseling? A meta-analysis of interventional trials. Am J Clin Nutr 92(4):678–687PubMedCrossRef

12.

Callaway L, Colditz PB, Fisk NM (2009) Folic acid supplementation and spontaneous preterm birth: adding grist to the mill? PLoS Med 6(5):e1000077PubMedCrossRef

13.

Chuang CH, Weisman CS, Hillemeier MM, Schwarz EB, Camacho FT, Dyer AM (2010) Pregnancy intention and health behaviors: results from the Central Pennsylvania Women’s Health Study cohort. Matern Child Health J 14(4):501–510PubMedCrossRef

14.

Harizopoulou VC, Kritikos A, Papanikolaou Z, Saranti E, Vavilis D, Klonos E, Papadimas I, Goulis DG (2010) Maternal physical activity before and during early pregnancy as a risk factor for gestational diabetes mellitus. Acta Diabetol 47(Suppl 1):83–89PubMedCrossRef

15.

Food and Agriculture Organization of the United Nations WHO (2001) Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO and WHO, Cordoba

16.

Greiner T, Backhed F (2011) Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab 22(4):117–123PubMedCrossRef

17.

Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Dore J, Meta HITC, Antolin M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Haimet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Lakhdari O, Layec S, Le Roux K, Maguin E, Merieux A, Minardi RM, M’Rini C, Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G, Weissenbach J, Ehrlich SD, Bork P (2011) Enterotypes of the human gut microbiome. Nature 473(7346):174–180PubMedCrossRef

18.

Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI (2009) A core gut microbiome in obese and lean twins. Nature 457(7228):480–484PubMedCrossRef

19.

Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101(44):15718–15723PubMedCrossRef

20.

Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102(31):11070–11075PubMedCrossRef

21.

Turnbaugh PJ, Backhed F, Fulton L, Gordon JI (2008) Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3(4):213–223PubMedCrossRef

22.

Backhed F (2009) Changes in intestinal microflora in obesity: cause or consequence? J Pediatr Gastroenterol Nutr 48(Suppl 2):S56–S57PubMedCrossRef

23.

Santacruz A, Marcos A, Warnberg J, Marti A, Martin-Matillas M, Campoy C, Moreno LA, Veiga O, Redondo-Figuero C, Garagorri JM, Azcona C, Delgado M, Garcia-Fuentes M, Collado MC, Sanz Y (2009) Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring) 17(10):1906–1915CrossRef

24.

Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027–1031PubMedCrossRef

25.

Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmee E, Cousin B, Sulpice T, Chamontin B, Ferrieres J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56(7):1761–1772PubMedCrossRef

26.

Collado MC, Isolauri E, Laitinen K, Salminen S (2008) Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 88(4):894–899PubMed

27.

Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Kling Backhed H, Gonzalez A, Werner JJ, Angenent LT, Knight R, Backhed F, Isolauri E, Salminen S, Ley RE (2012) Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150(3):470–480PubMedCrossRef

28.

Collado MC, Isolauri E, Laitinen K, Salminen S (2010) Effect of mother’s weight on infant’s microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr 92(5):1023–1030PubMedCrossRef

29.

Laitinen K, Poussa T, Isolauri E (2009) Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr 101(11):1679–1687PubMedCrossRef

30.

Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sorensen SJ, Hansen LH, Jakobsen M (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5(2):e9085PubMedCrossRef

31.

Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490(7418):55–60PubMedCrossRef

32.

Proal AD, Albert PJ, Marshall TG (2009) Dysregulation of the vitamin D nuclear receptor may contribute to the higher prevalence of some autoimmune diseases in women. Ann N Y Acad Sci 1173:252–259PubMedCrossRef

33.

Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, Drew JC, Ilonen J, Knip M, Hyoty H, Veijola R, Simell T, Simell O, Neu J, Wasserfall CH, Schatz D, Atkinson MA, Triplett EW (2011) Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 5(1):82–91PubMedCrossRef

34.

Kondo S, Xiao JZ, Satoh T, Odamaki T, Takahashi S, Sugahara H, Yaeshima T, Iwatsuki K, Kamei A, Abe K (2010) Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci Biotechnol Biochem 74(8):1656–1661PubMedCrossRef

35.

Andersson U, Branning C, Ahrne S, Molin G, Alenfall J, Onning G, Nyman M, Holm C (2010) Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse. Benef Microbes 1(2):189–196PubMedCrossRef

36.

Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen JL, Tian H, Li Y (2008) Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 149(9):4519–4526PubMedCrossRef

37.

Walker AW, Duncan SH, Leitch ECMW, Child MW, Flint HJ (2005) pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol 71(7):3692–3700PubMedCrossRef

38.

Mortensen FV, Nielsen H, Aalkjaer C, Mulvany MJ, Hessov I (1994) Short chain fatty acids relax isolated resistance arteries from the human ileum by a mechanism dependent on anion-exchange. Pharmacol Toxicol 75(3–4):181–185PubMedCrossRef

39.

Aronsson L, Huang Y, Parini P, Korach-Andre M, Hakansson J, Gustafsson JA, Pettersson S, Arulampalam V, Rafter J (2010) Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 5 (9):e13087. doi:10.1371/journal.pone.0013087

40.

Nerstedt A, Nilsson EC, Ohlson K, Hakansson J, Svensson LT, Lowenadler B, Svensson UK, Mahlapuu M (2007) Administration of Lactobacillus evokes coordinated changes in the intestinal expression profile of genes regulating energy homeostasis and immune phenotype in mice. Br J Nutr 97(6):1117–1127PubMedCrossRef

41.

Jeun J, Kim S, Cho SY, Jun HJ, Park HJ, Seo JG, Chung MJ, Lee SJ (2010) Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice. Nutrition 26(3):321–330PubMedCrossRef

42.

Paik HD, Park JS, Park E (2005) Effects of Bacillus polyfermenticus SCD on lipid and antioxidant metabolisms in rats fed a high-fat and high-cholesterol diet. Biol Pharm Bull 28(7):1270–1274PubMedCrossRef

43.

Abd El-Gawad IA, El-Sayed EM, Hafez SA, El-Zeini HM, Saleh FA (2005) The hypocholesterolaemic effect of milk yoghurt and soy-yoghurt containing bifidobacteria in rats fed on a cholesterol-enriched diet. Int Dairy J 15(1):37–44CrossRef

44.

Fukushima M, Yamada A, Endo T, Nakano M (1999) Effects of a mixture of organisms, Lactobacillus acidophilus or Streptococcus faecalis on delta6-desaturase activity in the livers of rats fed a fat- and cholesterol-enriched diet. Nutrition 15(5):373–378PubMedCrossRef

45.

Shin HS, Park SY, Lee DK, Kim SA, An HM, Kim JR, Kim MJ, Cha MG, Lee SW, Kim KJ, Lee KO, Ha NJ (2010) Hypocholesterolemic effect of sonication-killed Bifidobacterium longum isolated from healthy adult Koreans in high cholesterol fed rats. Arch Pharm Res 33(9):1425–1431PubMedCrossRef

46.

Ridlon JM, Kang DJ, Hylemon PB (2006) Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47(2):241–259PubMedCrossRef

47.

Ramasamy K, Abdullah N, Wong MC, Karuthan C, Ho YW (2010) Bile salt deconjugation and cholesterol removal from media by Lactobacillus strains used as probiotics in chickens. J Sci Food Agric 90(1):65–69PubMedCrossRef

48.

Chiang YR, Ismail W, Heintz D, Schaeffer C, Van Dorsselaer A, Fuchs G (2008) Study of anoxic and oxic cholesterol metabolism by Sterolibacterium denitrificans. J Bacteriol 190(3):905–914PubMedCrossRef

49.

Tok E, Aslim B (2010) Cholesterol removal by some lactic acid bacteria that can be used as probiotic. Microbiol Immunol 54(5):257–264PubMed

50.

Vrieze A, Holleman F, Zoetendal EG, de Vos WM, Hoekstra JB, Nieuwdorp M (2010) The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia 53(4):606–613PubMedCrossRef

51.

Chou CJ, Membrez M, Blancher F (2008) Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice. Nestle Nutr Workshop Ser Pediatr Program 62:127–137 discussion 137–140PubMedCrossRef

52.

Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E (2009) Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50(1):90–97PubMedCrossRef

53.

Licciardi PV, Wong SS, Tang ML, Karagiannis TC (2010) Epigenome targeting by probiotic metabolites. Gut Pathogens 2(1):24PubMedCrossRef

54.

Pessi T, Sutas Y, Hurme M, Isolauri E (2000) Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 30(12):1804–1808PubMedCrossRef

55.

Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, Marzotti S, Corneli RB, Ferretti E, Gulino A, Grasso F, De Simone C, Di Mario U, Falorni A, Boirivant M, Dotta F (2005) Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48(8):1565–1575PubMedCrossRef

56.

Kolb H, Mandrup-Poulsen T (2010) The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 53(1):10–20PubMedCrossRef

57.

Ljungberg M, Korpela R, Ilonen J, Ludvigsson J, Vaarala O (2006) Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes–the PRODIA study. Ann N Y Acad Sci 1079:360–364PubMedCrossRef

58.

Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y, Okano M, Kagoshima M, Tsuchida T (2010) Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 64(6):636–643PubMedCrossRef

59.

Lye HS, Kuan CY, Ewe JA, Fung WY, Liong MT (2009) The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 10(9):3755–3775PubMedCrossRef

60.

Sanz Y, Santacruz A, Gauffin P (2010) Gut microbiota in obesity and metabolic disorders. Proc Nutr Soc 69(3):434–441PubMedCrossRef

61.

Andreasen AS, Larsen N, Pedersen-Skovsgaard T, Berg RM, Moller K, Svendsen KD, Jakobsen M, Pedersen BK (2010) Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 104(12):1831–1838PubMedCrossRef

62.

Agerholm-Larsen L, Bell ML, Grunwald GK, Astrup A (2000) The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies. Eur J Clin Nutr 54(11):856–860PubMedCrossRef

63.

Ataie-Jafari A, Larijani B, Alavi Majd H, Tahbaz F (2009) Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann Nutr Metab 54(1):22–27PubMedCrossRef

64.

Anderson JW, Gilliland SE (1999) Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr 18(1):43–50PubMed

65.

Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A, Iwatsuki K, Kokubo S, Hosono A (2003) Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci 86(7):2452–2461PubMedCrossRef

66.

Greany KA, Bonorden MJ, Hamilton-Reeves JM, McMullen MH, Wangen KE, Phipps WR, Feirtag J, Thomas W, Kurzer MS (2008) Probiotic capsules do not lower plasma lipids in young women and men. Eur J Clin Nutr 62(2):232–237PubMedCrossRef

67.

Luoto R, Laitinen K, Nermes M, Isolauri E (2010) Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr 103(12):1792–1799PubMedCrossRef

68.

Ilmonen J, Isolauri E, Poussa T, Laitinen K (2011) Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: a randomized placebo-controlled trial. Clin Nutr 30(2):156–164PubMedCrossRef

69.

Aaltonen J, Ojala T, Laitinen K, Poussa T, Ozanne S, Isolauri E (2011) Impact of maternal diet during pregnancy and breastfeeding on infant metabolic programming: a prospective randomized controlled study. Eur J Clin Nutr 65(1):10–19PubMedCrossRef

70.

Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva A, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y, Schmidt MI (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33(3):676–682PubMedCrossRef

71.

Kaplas N, Isolauri E, Lampi AM, Ojala T, Laitinen K (2007) Dietary counseling and probiotic supplementation during pregnancy modify placental phospholipid fatty acids. Lipids 42(9):865–870PubMedCrossRef

72.

Boyle RJ, Ismail IH, Kivivuori S, Licciardi PV, Robins-Browne RM, Mah LJ, Axelrad C, Moore S, Donath S, Carlin JB, Lahtinen SJ, Tang ML (2011) Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy 66:509–516. doi:10.1111/j.1398-9995.2010.02507.x PubMedCrossRef

73.

Kopp MV, Goldstein M, Dietschek A, Sofke J, Heinzmann A, Urbanek R (2008) Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-gamma release of mononuclear cells but no in vivo effects in supplemented mothers and their neonates. Clin Exp Allergy 38(4):602–610PubMedCrossRef

74.

Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M (2008) Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 122(1):8–12PubMedCrossRef

75.

Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor M, Garaiova I, Plummer SF, Wang D, Morgan G (2010) Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. J Nutr 140(3):483–488PubMedCrossRef

76.

Deshpande G, Rao S, Patole S (2007) Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 369(9573):1614–1620PubMedCrossRef

77.

Hempel S, Newberry S, Ruelaz A, Wang Z, Miles JNV, Suttorp MJ, Johnsen B, Shanman R, Slusser W, Fu N, Smith A, Roth B, Polak J, Motala A, Perry T, Shelkelle PG (2011) Safety of probiotics to reduce risk and prevent or treat disease evidence reports/technology assessments. Agency for Healthcare Research and Quality (US), Rockville (MD)

78.

Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach J, Hormannsperger G, Huys G, Levy DD, Lutgendorff F, Mack D, Phothirath P, Solano-Aguilar G, Vaughan E (2010) Safety assessment of probiotics for human use. Gut Microbes 1(3):164–185PubMedCrossRef

79.

Elias J, Bozzo P, Einarson A (2011) Are probiotics safe for use during pregnancy and lactation? Can Fam Physician 57(3):299–301PubMed

80.

Luoto R, Kalliomaki M, Laitinen K, Isolauri E (2010) The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes Lond 34(10):1531–1537PubMedCrossRef

81.

Piirainen T, Isolauri E, Lagstrom H, Laitinen K (2006) Impact of dietary counselling on nutrient intake during pregnancy: a prospective cohort study. Br J Nutr 96(6):1095–1104PubMedCrossRef

82.

Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS (2004) Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women. J Nutr 134(12):3277–3283PubMed

83.

Kopp MV, Hennemuth I, Heinzmann A, Urbanek R (2008) Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121(4):e850–e856PubMedCrossRef

Title: Probiotics: a potential role in the prevention of gestational diabetes?
Authors: Helen L. Barrett
Leonie K. Callaway
Marloes Dekker Nitert
Publication date: 01-12-2012
Publisher: Springer Milan
Published in: Acta Diabetologica / Issue Special Issue 1/2012
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-012-0444-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2012

Associations of hip circumference and height with incidence of type 2 diabetes: the Isfahan diabetes prevention study

Index of glucose effectiveness derived from oral glucose tolerance test

Rosiglitazone decreases fasting plasma peptide YY3–36 in type 2 diabetic women: a possible role in weight gain?

Expression of leptin and its long-form receptor in the marginal cutaneous tissues of diabetic foot ulcers

The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM)

Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials